People with Alzheimer’s disease (AD) often have better quality of life when they continue living at home, but staying at home can be a challenge for both the patient and caregiver.

Looking for biomarkers of Alzheimer’s disease (AD) may lead scientists to new treatments. Biomarkers are proteins found in the body that are linked to AD.

Recent research found that changes in the brain and body may begin years before symptoms of Alzheimer’s di sease (AD) begin.

Mild cognitive impairment (MCI) can progress into other forms of dementia, like Alzheimer’s disease. Science is trying to find ways to predict when MCI will get worse.

Researchers are learning how Alzheimer’s disease (AD) changes the brain. Memory loss is thought to result from brain cell damage, but how the damage happens is not totally clear.

You've seen them in parks or in films: rows of older men and women moving through the slow, graceful movements of tai chi. And it may be more than their bodies that they are improving.

Medications for treating Alzheimer’s disease (AD) have been suspected to influence heart function. New research finds that heart function was not affected over four weeks of treatment.

Omega-3 fatty acids are reported to protect brain cells during aging thereby protecting cognitive function. But a recent systematic review of the evidence calls into question these proposed cognitive benefits.

For the first time in humans, researchers have shown that there is a link between the immune system and age-related memory decline.

New technologies and guidelines may help scientists better understand the Alzheimer’s Disease (AD) brain before symptoms appear, which may lead to earlier detection in future generations.